ARWR earnings date and history (2026)
Arrowhead Pharmaceuticals Inc. (ARWR) next reports earnings on Tue Nov 24. Analysts expect EPS of -$1.59 (9 estimates), against -$0.18 in the same quarter a year ago. Last time, on Tue Aug 4, it reported -$1.36 against a -$1.23 consensus (-10.6%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Aug 4, 2026 | -$1.23 | -$1.36 | — |
| May 7, 2026 | -$1.18 | -$0.93 | — |
| Feb 5, 2026 | $0.60 | $0.22 | — |
| Nov 25, 2025 | $0.12 | -$0.18 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does ARWR report earnings?
- ARWR is scheduled to report on Tue Nov 24, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from ARWR?
- The consensus estimate is -$1.59 a share across 9 analysts; the same quarter a year ago came in at -$0.18.
- Did ARWR beat earnings last quarter?
- No: on Tue Aug 4 ARWR reported -$1.36 against a -$1.23 consensus, a -10.6% surprise.